Trial NCT02468557

View at ClinicalTrials.gov 
Org. Study IDs: GS-US-385-1577

Last trial update was posted on 2021-04-02

MeSH Interventions

Idelalisib Paclitaxel

MeSH Conditions

Adenocarcinoma

Other Conditions

Previously Untreated Pancreatic Ductal Adenocarcinoma Relapsed/Refractory Pancreatic Ductal Adenocarcinoma

Stopping Reasons

N/A

Limitations And Caveats

Due to the early termination of the study, the prespecified efficacy, pharmacodynamic, and pharmacokinetic analysis for PK parameters were not conducted.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID